ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong...
ASP Isotopes traded nearly flat on July 2, closing at $6.17, unchanged from the prior close, after a slight dip to $6.15 in pre-market recovery. The stock oscillated in a narrow $6.115-$6.465 range intraday. Recent insider selling has weighed: Director Michael Gorley sold 30,000 shares for ~$188,100, and another director unloaded shares worth over $618K. The company's HALEU supply MOU and business update call failed to reverse the downward sentiment. On earnings, Q1 2026 revenue surged 279% YoY to $4.18M, but operating loss widened to $24.9M, while net loss narrowed to $6.88M. Price-wise, the stock sits 6.7% below its 20-day MA ($6.61) and 2.7% above the 60-day MA ($6.01), 57% off the 52-week high of $14.49, yet up ~9.6% YTD. Post-market edged up to $6.18 on thin volume.
From Nuclear Tech to AI Liquid Cooling: Unpacking Micro-Cap Overhauls
ASP Isotopes Maps Noble Africa Listing as Helium Project Nears Production
ASP Isotopes subsidiary Quantum Leap Energy signs uranium conversion research deal with Texas A&M TEES
Is ASP Isotopes' (ASPI) New Shelf Registration Reframing Its Long‑Term Capital Strategy?
Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company | ASPI Stock News
ASP Isotopes swaps $109.2 million QLE notes for 23,200,000 shares in private exchange deal